Tom Price's confirmation chances now seem weaker than any other Trump pick, Jake Novak explains why. » Read More
By: Ezra Klein
How can the Trump administration replace Obamacare without falling flat on its face? Tell the states to do it instead, says Vox's Ezra Klein. » Read More
By: Jordan Chariton
Elizabeth Warren has some explaining to do if she wants support from progressives in 2020, says Jordan Chariton. » Read More
While Asia is progressing on the integration front, the European Union appears to be unraveling. » Read More
Terry Tamminen, who met with President-elect Trump and Leonoardo DiCaprio in December, explains how a Trump climate-change deal with China might work.
Depending on the outcome of Trump's bet, the economy could break free of its lethargy or end up in a deep recession, says Jay N. Rollins.
Health care services in Costa Rica are a fraction of the cost of the U.S., yet every bit as good, says John Michael Arthur.
The market moved up so fast after the election that investors got spooked. But JPMorgan's earnings show the rally is for real.
It's becoming obvious Big Pharma's iron wall of protection in Washington is starting to crumble, says Jake Novak.
More government regulation is not the answer to emissions cheating, says Prof. Timothy Carone. Here's what will help.
Herbert Hoover had no government experience. And we all know how that turned out, says Dustin McKissen.
Automakers have been gaming the system for years when it comes to environmental rules, says Jake Novak. Fiat and VW just went too far.
In an op-ed for CNBC, T-Mobile CEO John Legere explains why he's ticked off about what's going on in the mobile industry.
Turney Duff explains why traders jumped on Trump rally and why they may be jumping off now.
The department chain's closures can be attributed to complacency, not online shopping competition, says Recode's Jason Del Ray.
Trump and the GOP can get a quickie Obamacare plan passed, but it will rely on slick packaging and promotion, says Jake Novak.
Wall Street is seeing an $8.7 trillion boom in this investment strategy, says David W. Richardson.
President-elect Trump's plans for student debt compare favorably to existing options, but it remains to be seen if they will be enacted.
Mark Macias says he'd give Donald Trump a B+ for his first press conference since the election. Here's why.
Big Pharma better come to the negotiating table if it wants to survive the Trump era, says Jake Novak.